Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Ana Rita Rodrigues-Barata"'
Publikováno v:
European Medical Journal Dermatology, Vol 2, Iss 1, Pp 101-105 (2013)
Methylisothiazolinone (MI), along with Kathon™ CG (methylchloroisothiazolinone/MI), are widely used preservatives to prevent bacterial overgrowth in aqueous solutions of various types of cosmetic, household, and industrial products. Because of it
Externí odkaz:
https://doaj.org/article/6bb1c15fd6164b369d9422bab30ca2e8
Autor:
Carolina Granados Rincón, Nelly Machado Benavides, Ana Rita Rodrigues-Barata, Luis Conde-Salazar Gómez
Publikováno v:
Medicina y Seguridad del Trabajo, Vol 59, Iss 230, Pp 74-84 (2013)
Dentro de la Medicina Laboral las dermatosis ocupacionales suponen entre el 30-60% del total de enfermedades profesionales y, dentro de ellas el 80-90% son dermatitis de contacto. Este alto número no se ve reflejado en datos oficiales debido a que e
Externí odkaz:
https://doaj.org/article/b36069a268c94f34854f6c43c5ef0c20
Autor:
C. Bernárdez, David Saceda-Corralo, Sergio Vano-Galvan, Ana Rita Rodrigues-Barata, Rocío Gil-Redondo, Oscar M. Moreno-Arrones, Ángela Hermosa-Gelbard
Publikováno v:
Journal of the American Academy of Dermatology. 86:181-183
Autor:
Oscar M. Moreno-Arrones, Cristina Pindado-Ortega, Sergio Vano-Galvan, David Saceda-Corralo, Ana Rita Rodrigues-Barata, Ángela Hermosa-Gelbard, Pedro Jaén-Olasolo
Publikováno v:
Journal of the American Academy of Dermatology. 84:1285-1294
Background Dutasteride has been proposed as an effective therapy for frontal fibrosing alopecia (FFA). Objectives We sought to describe the therapeutic response to dutasteride and the most effective dosage in FFA compared with other therapeutic optio
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 88, Iss 4, Pp 611-613 (2013)
Protein contact dermatitis is a skin condition not well known and underdiagnosed by dermatologists, resulting from an IgE-mediated allergic reaction. Clinically it presents as a chronic hand and/or forearms eczema of occupational origin, especially i
Externí odkaz:
https://doaj.org/article/5a0c98135e4341869e562e2be5ff8b9c
Autor:
Pedro Jaén-Olasolo, Ángela Hermosa-Gelbard, Sergio Vano-Galvan, Ana Rita Rodrigues-Barata, David Saceda-Corralo, Oscar M. Moreno-Arrones, Cristina Pindado-Ortega
Publikováno v:
Journal of the American Academy of Dermatology. 85:e95-e96
Autor:
J. Cuevas‐Santos, Oscar M. Moreno-Arrones, David Saceda-Corralo, Pedro Jaén-Olasolo, R. Gil‐Redondo, Ana Rita Rodrigues-Barata, Sergio Vano-Galvan
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 34
Autor:
David Saceda-Corralo, Sergio Vano-Galvan, Ramon Grimalt, Salvador Arias-Santiago, Ana Rita Rodrigues-Barata, Pablo Fernández-Crehuet, Pedro Jaén-Olasolo, Cristina Serrano-Falcón, Ana María Molina-Ruiz, Didac Barco, Antonio Martorell-Calatayud, Francisco Camacho, Laura Miguel-Gomez
Publikováno v:
Journal of the American Academy of Dermatology. 79:878-883
Background Folliculitis decalvans (FD) is a rare neutrophilic cicatricial alopecia that poses a therapeutic challenge. Objectives To describe the therapeutic response in a large number of cases of FD with long-term follow-up and analyze potential pro
Autor:
Pablo Fonda-Pascual, Pablo Fernandez-Gonzalez, David Saceda-Corralo, D. Buendía-Castaño, Cristina Pindado-Ortega, Sergio Vano-Galvan, Oscar M. Moreno-Arrones, A. Alegre-Sánchez, Ana Rita Rodrigues-Barata
Publikováno v:
Actas Dermo-Sifiliográficas. 109:536-542
Resumen Introduccion A pesar de que los unicos farmacos con indicacion aprobada en nuestro pais para la alopecia androgenica (AGA) son minoxidil topico y finasterida oral, es comun la utilizacion de numerosas terapias fuera de indicacion, provocando
Autor:
Oscar M. Moreno-Arrones, A. Alegre-Sánchez, Cristina Pindado-Ortega, Pablo Fonda-Pascual, Sergio Vano-Galvan, Pablo Fernandez-Gonzalez, Ana Rita Rodrigues-Barata, D. Buendía-Castaño, David Saceda-Corralo
Publikováno v:
Actas Dermo-Sifiliográficas (English Edition). 109:536-542
Background Topical minoxidil and oral finasteride are the only drugs approved for the treatment of androgenetic alopecia (AGA) in Spain. However, the management of this condition is highly variable because numerous treatments are used off-label. The